BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  ACELYRIN, INC. to Report Second Quarter 2024 Financial Results and Corporate Update on August 13, 2024

  August 6, 2024

   · 

  1 min read
• FDA

  Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Viewpoint Catheter, further addressing market need to reduce physician exposure to harmful x-ray radiation during image-guided, endovascular procedures

  August 6, 2024

   · 

  2 min read
• Business

  Emergent BioSolutions Reports Second Quarter 2024 Financial Results

  August 6, 2024

   · 

  41 min read
• Business

  Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024

  August 6, 2024

   · 

  2 min read
• Business

  Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

  August 6, 2024

   · 

  30 min read
• Business

  STERIS Announces Financial Results for Fiscal 2025 First Quarter

  August 6, 2024

   · 

  14 min read
• Business

  UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates

  August 6, 2024

   · 

  7 min read
• Business

  Cellectis Provides Financial Results for the Second Quarter 2024

  August 6, 2024

   · 

  24 min read
• FDA

  Servier’s VORANIGO® (vorasidenib) Tablets Receives FDA Approval as First Targeted Therapy for Grade 2 IDH-mutant Glioma

  August 6, 2024

   · 

  12 min read
• Business

  Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

  August 6, 2024

   · 

  15 min read